Federal contract award
75F40124P00336
MONOCLONAL ANTIBODIES PRODUCTION CLONES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AJ12 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $52.5K |
| Current contract value | $52.5K |
| Potential contract value / ceiling | $52.5K |
| Start date | Aug 1, 2024 |
| Current end date | Jul 31, 2025 |
| Potential end date | Oct 24, 2025 |
| Latest award activity | Sep 8, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 8, 2026 | P00002 | $0 | MONOCLONAL ANTIBODIES PRODUCTION CLONES |
| Oct 23, 2025 | P00001 | $0 | MONOCLONAL ANTIBODIES PRODUCTION CLONES |
| Aug 1, 2024 | 0 | $52.5K | MONOCLONAL ANTIBODIES PRODUCTION CLONES |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.